Forest Laboratories, Inc. (FRX) Reports Q2 Miss; Reaffirms FY12 Outlook
Tweet
Share
E-mailGet Alerts FRX Hot Sheet
Join SI Premium – FREE
Forest Laboratories, Inc. (NYSE: FRX) reported Q2 EPS of $0.91, $0.08 worse than the analyst estimate of $0.99. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.15 billion.
Reaffirms guidance.
Reaffirms guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
